June 13, 2019 Life Science Tools Product Launch

At ESHG 2019 Paragon Genomics Presents Data Highlighting Accuracy, Scalability and Speed of CleanPlex® Target Enrichment Technology and Introduces CleanPlex Products for MGI Sequencers

— Two CleanPlex® Ready-to-Use and CleanPlex Custom NGS Panels Now Available for MGI Sequencers — Partner MGI Hosting Satellite Session that Includes Discussion of CleanPlex Panels for MGI Products — Partner Sophia Genetics Hosting Satellite Session Discussing Use of CleanPlex Custom NGS Panel with SOPHiA Genomic Analysis Platform for Rapid Profiling of Hereditary Disease Variants — ESHG Posters Show... Read more

June 13, 2019 Life Science Tools

Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants

MENLO PARK, Calif., June 13, 2019 (GLOBE NEWSWIRE) — While DNA sequencing tools have been useful for determining the genetic cause of many diseases, there remain a large number that are left unexplained. Recently, scientists have adopted Single Molecule, Real-Time (SMRT®) Sequencing from Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing... Read more

June 12, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Saphetor SA and Swift Biosciences Announce Partnership to Standardize and Accelerate Data Interpretation for Targeted NGS Panels

Lausanne, June 12th, 2019 Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.... Read more

June 6, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Konica Minolta to Join Global Oncogenic Gene Panel Research

Move Strengthens Konica Minolta’s Advance into Personalized Medicine in Japan with Next-Generation Screening Capabilities Tokyo (June 6, 2019) – Konica Minolta, Inc. (Konica Minolta) today announces agreement with the University of Tokyo (UTokyo) and the National Cancer Center Japan (NCC) to research and develop the next generation Todai OncoPanel (TOP) , a world-leading oncogenic panel test.... Read more

June 6, 2019 Environ, Ag./Food & Bev Life Science Tools M&A, Partnerships

BGI Partners With NRGene to Provide a Full Suite of Breeding Tools for the Chinese Market

Collaboration assures BGI’s and NRGene’s commitment to provide the most advanced technological breeding tools the Asian market June 6, 2019, Ness Ziona, Israel and Shenzhen, China BGI, the world’s largest omics organization, announced today that it will be offering NRGene’s technology as part of its broad genomics analysis services in agriculture research. BGI supports genomic... Read more

June 6, 2019 Environ, Ag./Food & Bev Life Science Tools Product Launch

NRGene Introduces New Product to Provide Whole Genome Assembly at Significantly Lower Cost

New product offers complete genome coverage and high accuracy for Denovo assembling reference level genomes at a much lower cost to accelerate agricultural research NESS ZIONA, Israel, and SAN DIEGO, June 6, 2019 — NRGene, a worldwide leader in genomic analysis for research and agricultural breeding, announced today the launch of DeNovoMAX – a new product that aims... Read more

June 4, 2019 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne to Acquire B-MoGen Biotechnologies Inc.

JUNE 04, 2019 MINNEAPOLIS, June 4, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through available cash on hand. “We are very pleased to include the B-MoGen technology in Bio-Techne’s expanding portfolio... Read more

June 4, 2019 Clinical Research/Diagn. Lab Top-10 Life Science Tools Product Launch

Illumina Introduces Expanded Version of VeriSeq™ NIPT Solution, Offering More Comprehensive Detection of Rare Chromosomal Conditions

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the launch of VeriSeq™ NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT). The automated comprehensive solution allows laboratories to screen for a broader range of chromosomal and sub-chromosomal conditions associated with birth defects and adverse pregnancy outcomes than the standard NIPT... Read more